mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.08 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.09 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.09 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.09 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.09 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.09 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.09 |